Clinical implications of leukocyte infiltration at the choroid plexus in (neuro)inflammatory disorders

Drug Discov Today. 2015 Aug;20(8):928-41. doi: 10.1016/j.drudis.2015.05.003. Epub 2015 May 13.

Abstract

The choroid plexus (CP) is a highly vascularized organ located in the brain ventricles and contains a single epithelial cell layer forming the blood-cerebrospinal fluid barrier (BCSFB). This barrier is crucial for immune surveillance in health and is an underestimated gate for entry of immune cells during numerous inflammatory disorders. Several of these disorders are accompanied by disturbance of the BCSFB and increased leukocyte infiltration, which affects neuroinflammation. Understanding the mechanism of immune cell entry at the CP might lead to identification of new therapeutic targets. Here, we focus on current knowledge of leukocyte infiltration at the CP in inflammatory conditions and its therapeutic implications.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / therapeutic use
  • Capillary Permeability* / drug effects
  • Central Nervous System Diseases / cerebrospinal fluid
  • Central Nervous System Diseases / drug therapy
  • Central Nervous System Diseases / immunology*
  • Central Nervous System Diseases / metabolism
  • Chemotaxis, Leukocyte* / drug effects
  • Choroid Plexus / drug effects
  • Choroid Plexus / immunology*
  • Choroid Plexus / metabolism
  • Choroid Plexus / pathology
  • Humans
  • Leukocytes / drug effects
  • Leukocytes / immunology*
  • Leukocytes / metabolism
  • Leukocytes / pathology
  • Meningitis / cerebrospinal fluid
  • Meningitis / drug therapy
  • Meningitis / immunology
  • Molecular Targeted Therapy
  • Multiple Sclerosis / cerebrospinal fluid
  • Multiple Sclerosis / drug therapy
  • Multiple Sclerosis / immunology
  • Signal Transduction
  • Spinal Cord Injuries / cerebrospinal fluid
  • Spinal Cord Injuries / drug therapy
  • Spinal Cord Injuries / immunology
  • Transendothelial and Transepithelial Migration* / drug effects

Substances

  • Anti-Inflammatory Agents